tradingview.comOCT 261 min read$CCEP

REG - Coca-Cola EP PLC - Transactions in Own Shares

Coca-Cola Europacific Partners (CCEP) repurchased 199,209 shares from 19-23 Oct 2026 as part of its EUR 1B share buyback program. The shares were bought from Goldman Sachs on US and London trading venues and will be cancelled. CCEP is listed on multiple exchanges, including NASDAQ and LSE, under the symbol CCEP.

Original reporting

tradingview.com

Published Oct 26, 2026, 1:30 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 26, 2026, 1:56 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

REG - Coca-Cola EP PLC - Transactions in Own Shares — source image — Source · tradingview.com

Decision brief

The 30-second read

$CCEPNeutralLow

Why it matters

The repurchase reduces share count, offering a modest boost to earnings per share and signaling confidence in cash flow.

Market read

A routine buyback tranche with limited market impact; primarily of interest to CCEP shareholders.

What to watch

Potential future larger tranches of the €1 billion programme could have cumulative impact if announced.

Relevance 5/10Novelty 4/10Timing: same-day announcement

Background

Coca-Cola Europacific Partners announced a share buyback programme in February 2026 targeting up to €1 billion. This filing reports the first tranche of that programme.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$CCEPNeutralHigh confidence

Context

Coca-Cola Europacific Partners disclosed a share repurchase of 150,000 US-listed shares and 49,209 London-listed shares, which will be cancelled.

Expected impact

likely slight upward pressure as the market prices the share reduction

Evidence & confidence

The tranche is small relative to the €1 billion programme, so impact is limited but the cancellation of shares is a positive signal.

Market effects

Sector

Minimal effect on the consumer staples sector; reinforces ongoing buyback trend among large beverage companies.

Regional

Limited to European and US markets where CCEP trades.

Global

Low; does not affect broader market dynamics.

Counterpoint

What could challenge this read

The buyback size is negligible and may not justify any price move; investors could focus on larger strategic developments.

Key entities

company
Coca-Cola Europacific Partners plc
Consumer beverages company listed on NASDAQ, LSE, and Euronext.
intermediary
Goldman Sachs & Co. LLC
Seller of the repurchased shares.

Read at source ← All news

OCT 5

$CCEPMed

UBS reiterates Neutral rating on Coca-Cola Europacific Partners stock

UBS reiterated a Neutral rating on Coca-Cola Europacific Partners (CCEP) with a $107.00 price target, citing 5.4% Q3 organic sales growth forecast. The stock trades at $100.50, above InvestingPro’s Fair Value estimate. UBS expects growth in Europe and Asia Pacific, with potential for raised full-year revenue guidance. CCEP reported H1 2026 revenue of EUR 10.7 billion, up 6.1%, and EPS growth of 10.6%. Analysts have mixed views on its valuation and outlook.

investing.com2 min

SEP 24

Low

Coca Cola Europacific Partners (ENXTAM:CCEP) Board Exit Leaves Its Undervalued Case In Focus

Coca-Cola Europacific Partners (CCEP) is under scrutiny after independent non-executive director Nathalie Gaveau resigned, prompting a review of board roles. The company's share price is €88.3, down 6.26% over the past month but up 17.42% year-to-date and 116.77% over five years. Analysts suggest CCEP is 8% undervalued with a fair value of €95.68, citing strong long-term growth prospects in emerging markets and digital investments.

simplywall.st2 min

SEP 14

$CCEPHigh

Transactions in Own Shares

Coca-Cola Europacific Partners (CCEP) repurchased 403,748 ordinary shares from 7 to 11 September 2026, totaling approximately $43.5 million (USD) and £31.2 million (GBP) on US and London trading venues, respectively. The shares were bought as part of the company's EUR 1 billion share buyback program announced in February 2026. The repurchased shares will be cancelled.

investegate.co.uk2 min

SEP 4

$CCEPHigh

CCEP slips as a fresh Wall Street downgrade adds to valuation concerns

Coca-Cola Europacific Partners (CCEP) fell 3.1% after J.P. Morgan re-initiated coverage with an Underweight rating and a $92 price target, citing valuation concerns and potential slowdown in volume growth. The stock has faced scrutiny due to its premium valuation, despite solid first-half 2026 results. Institutional investors have recently adjusted their positions in CCEP.

quiverquant.com2 min

AUG 13

$CCEPMed

UBS Cuts Coca-Cola Europacific Partners to Neutral, Citing Stretched Valuation

UBS downgraded Coca-Cola Europacific Partners (LON: CCEP) to Neutral from Buy, cutting its price target to $107 from $109. Analyst Sanjeet Aujla cited stretched valuation after the stock rose 19% year-to-date and now trades about 20% above European staples peers. UBS said the downgrade is not tied to weaker operations and noted guidance could still be raised.

asktraders.com3 min

AUG 8

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.

aol.com4 min